The figs market has been in a phase of consolidation for almost two years. It was confined to the $4.42 and the $6.97 support and resistance level during this time, and missed the stock boom in the United States. The brand was valued at $1.12 billion at the time it traded at $6.25.
Brands facing challenges
Figs, an apparel brand that specializes in the healthcare industry. Direct-to-consumer, it sells healthcare apparel nationwide to doctors and nurses.
The US healthcare industry has more than 22 million social and health workers. This number will grow as the US population grows older. Over $12 billion is thought to be the value of healthcare apparel.
Figs is a company that has been around for many years. It served more than 1.2 millions people in the US, according to its 10k.
The competition within the industry is Figs’ biggest obstacle. The company’s main competitors are Uniform Advantage and Scrubs & Beyond, along with mass-market and wholesale retailers.
Figs has seen its business continue to grow in recent years. It generated more than $110 million of revenue in 2019, and $545 million by 2023. The company’s marketing budget was increased and its brand recognition improved.
Ron Baron shares one of his biggest recent investments
Recent signs suggest that the business of this company is slowing down, probably due to intense competition. The number of Figs customers increased by 4% in the past year to reach 2.6 millions, while the average revenue per customer fell by 3%. Average order values also fell by 5%, to $108. This data explains why the Figs share price is not doing well.
Figs’ revenue also declined by 1.5% in the third-quarter, to $140 millions, and its gross margins continued to decline. This trend was attributed by Figs to the increased discounting as a result of increasing competition. In Q3 ’23, the gross margin was 68.4%. The latest numbers show a gross profit of 67.1%. The figure is down after reaching a peak of 72% in FY ’20.
Analysts have a pessimistic view of the company, as they face significant challenges. In 2025, Figs’ revenue is expected to increase by 3% and reach $559 millions.
Another key issue is the fact that this company’s P/E forward ratio of 350 is a bit overvalued. The firm’s balance sheet is strong, as it has over $281 in short-term and cash investments.
Stock price Analysis of Figs
On the daily chart, it is clear that Figs’ share price reached its lowest point at $4.42 by 2024. The price has failed to fall below this level on several occasions since April. This is a sign of short sellers not being comfortable with placing trades under that point.
Stock then hit a major barrier of $6.97. This was its biggest swing since July and October that same year. The stock has risen slightly above its 50-day moving mean, and the Percentage price oscillator (PPO), has climbed above zero.
The accumulation and distribution index is showing signs of rising. It has also remained over the trendline ascending that links its lowest swings from February.
It is likely that, despite its poor fundamentals, the stock will have a big comeback by 2025. The stock could jump up to $10.25 which is 66% higher than the current price. It is important to note that this price is near the peak of February 2023.
The price of this post Figs is in a narrow range. Will it break out in 2025 or not? This information may change as new developments unfold
This site is for entertainment only. Click here to read more
